Published in J Am Coll Cardiol on January 16, 2002
Soy Nut Study on Markers of Health | NCT01173380
Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients | NCT01501929
Steroids and Microcirculation In Cardiac Surgery (SICS) | NCT02798068
Nitric Oxide Supplementation in Argininosuccinic Aciduria | NCT02252770
Effect of Probiotic Supplementation on Endothelial Function II | NCT03267758
Resistance Training and Cardiometabolic Health | NCT03325933
Endothelial Function in Mechanical Circulatory Support | NCT04539093
Cardiovascular Risk in Infants Exposed to Pre-eclampsia in Utero | NCT05091827
Effects of Low Intensity Therapeutic Ultrasound on Endothelial Function | NCT02872922
Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation (2008) 4.61
Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol (2010) 4.42
Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol (2004) 3.48
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol (2008) 3.36
Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol (1985) (2008) 3.25
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol (2012) 3.19
The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol (2005) 3.09
(-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A (2006) 3.03
Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation (2004) 2.79
Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol (2004) 2.75
The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68
Ultrasound assessment of flow-mediated dilation. Hypertension (2010) 2.48
Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation (2008) 2.33
25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension (2010) 2.33
Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity. J Appl Physiol (1985) (2008) 2.29
Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation (2008) 2.28
Diesel exhaust inhalation elicits acute vasoconstriction in vivo. Environ Health Perspect (2008) 2.21
The effect of weight loss and exercise training on flow-mediated dilatation in coronary heart disease: a randomized trial. Chest (2011) 2.15
Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol (2009) 2.09
eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab (2009) 2.04
Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res (2011) 2.03
Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med (2007) 1.90
Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol (2011) 1.85
Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res (2006) 1.84
Endothelial dysfunction induced by post-prandial lipemia: complete protection afforded by high-intensity aerobic interval exercise. J Am Coll Cardiol (2009) 1.83
Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption. Hypertension (2012) 1.79
Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension (2010) 1.77
Measuring FMD in the brachial artery: how important is QRS gating? J Appl Physiol (1985) (2010) 1.75
Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol (2011) 1.72
Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol (2006) 1.72
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS (2009) 1.67
Sprint interval and traditional endurance training induce similar improvements in peripheral arterial stiffness and flow-mediated dilation in healthy humans. Am J Physiol Regul Integr Comp Physiol (2008) 1.62
Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Am J Physiol Heart Circ Physiol (2012) 1.62
Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans. J Physiol (2007) 1.61
Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea. Med Sci Monit (2012) 1.61
Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol (2010) 1.61
Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation (2010) 1.60
High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans. J Hypertens (2013) 1.59
Time course of change in vasodilator function and capacity in response to exercise training in humans. J Physiol (2008) 1.57
Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther (2010) 1.55
Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol (2007) 1.53
Endothelial dysfunction: associations with exposure to ambient fine particles in diabetic individuals. Environ Health Perspect (2008) 1.53
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol (2011) 1.52
Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease. J Appl Physiol (1985) (2011) 1.52
Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol (2010) 1.51
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. Kidney Int (2006) 1.50
Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke (2007) 1.49
Secondhand Smoking Is Associated With Vascular Inflammation. Chest (2015) 1.48
Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr (2010) 1.47
Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults. J Appl Physiol (1985) (2011) 1.47
Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol (2013) 1.47
Both flow-mediated vasodilation procedures and acute exercise improve endothelial function in obese young men. Eur J Appl Physiol (2010) 1.47
The relationship between IL-10 levels and cardiovascular events in patients with CKD. Clin J Am Soc Nephrol (2014) 1.46
Reversal of experimental renovascular hypertension restores coronary microvascular function and architecture. Am J Hypertens (2011) 1.45
Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care (2011) 1.45
Depression and coronary heart disease. Nat Rev Cardiol (2016) 1.45
A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One (2012) 1.44
Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus. Rheumatol Int (2013) 1.41
Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care (2009) 1.41
A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease. Can J Cardiol (2015) 1.40
Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol (2009) 1.40
Sex differences in the endothelial function of untreated hypertension. J Clin Hypertens (Greenwich) (2012) 1.39
Vascular inflammation in obesity and sleep apnea. Circulation (2010) 1.38
Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg (2009) 1.35
Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. J Am Coll Cardiol (2013) 1.34
Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep (2010) 1.34
Update on nitric oxide-dependent vasodilation in human subjects. Methods Enzymol (2005) 1.34
Passive heat therapy improves endothelial function, arterial stiffness and blood pressure in sedentary humans. J Physiol (2016) 1.33
Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol (2008) 1.33
Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovasc Disord (2007) 1.32
Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol (2009) 1.32
Impact of shear rate modulation on vascular function in humans. Hypertension (2009) 1.31
Differential responses to CO2 and sympathetic stimulation in the cerebral and femoral circulations in humans. J Physiol (2005) 1.31
Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr (2007) 1.30
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells. EBioMedicine (2015) 1.29
Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis (2013) 1.27
Central, peripheral and resistance arterial reactivity: fluctuates during the phases of the menstrual cycle. Exp Biol Med (Maywood) (2010) 1.27
Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease. Blood (2015) 1.25
Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients. J Am Heart Assoc (2013) 1.24
Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults. Clin Sci (Lond) (2011) 1.24
Determinants of vascular function in patients with type 2 diabetes. Cardiovasc Diabetol (2012) 1.24
Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med (2006) 1.24
Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol (2012) 1.23
The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an "endothelial resistance" to glucagon-like peptide 1 in diabetes. Diabetes Care (2011) 1.23
Ultrasound settings significantly alter arterial lumen and wall thickness measurements. Cardiovasc Ultrasound (2008) 1.23
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS (2013) 1.23
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J (2008) 1.22
Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol (2008) 1.22
The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J (2010) 1.21
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS (2012) 1.21
Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes (2012) 1.21
Plasma nitrite response and arterial reactivity differentiate vascular health and performance. Nitric Oxide (2009) 1.20
Effect of resistance training on arterial wave reflection and brachial artery reactivity in normotensive postmenopausal women. Eur J Appl Physiol (2007) 1.20
A single air dive reduces arterial endothelial function in man. J Physiol (2005) 1.19
Endothelial dysfunction in obstructive sleep apnea. J Clin Sleep Med (2007) 1.19
Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart (2005) 1.17
Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2008) 1.15
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 9.35
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75
Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med (2004) 7.62
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med (2004) 7.12
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet (2005) 6.59
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Aortic stiffness, blood pressure progression, and incident hypertension. JAMA (2012) 6.01
Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation (2006) 5.99
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell (2007) 5.85
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med (2009) 5.34
Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med (2008) 5.34
Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation (2006) 5.31
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet (2009) 5.23
Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA (2009) 5.22
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10
The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02
Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med (2004) 4.92
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85
Treatment of periodontitis and endothelial function. N Engl J Med (2007) 4.83
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation (2008) 4.69
Incidence and prognosis of syncope. N Engl J Med (2002) 4.69
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med (2008) 4.61
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J (2006) 4.57
Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension (2004) 4.56
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
Impact of obesity on plasma natriuretic peptide levels. Circulation (2004) 4.46
Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med (2006) 4.36
Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation (2005) 4.20
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation (2010) 4.12
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09
Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation (2005) 4.08
Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol (2004) 4.07
Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension (2008) 3.99
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet (2009) 3.81
National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation (2005) 3.77
Genome-wide association study of PR interval. Nat Genet (2010) 3.73